Pharmax Corporation Profile
Key Indicators
- Authorised Capital ₹ 28.70 Cr
as on 18-06-2024
- Paid Up Capital ₹ 7.71 Cr
as on 18-06-2024
- Company Age 35 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 228.00 Cr
as on 18-06-2024
- Satisfied Charges ₹ 65.00 Cr
as on 18-06-2024
- Revenue 98.56%
(FY 2023)
- Profit 442.31%
(FY 2023)
- Ebitda 278.98%
(FY 2023)
- Net Worth -34.90%
(FY 2023)
- Total Assets 59.18%
(FY 2023)
About Pharmax Corporation
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 28.70 Cr and a paid-up capital of Rs 7.71 Cr.
The company currently has active open charges totaling ₹228.00 Cr. The company has closed loans amounting to ₹65.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kishansingh Ramsinghaney, Rishi Raj, and Anshul Gaurav serve as directors at the Company.
- CIN/LLPIN
U24232PB1989PLC009741
- Company No.
009741
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Sep 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Punjab, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pharmax Corporation?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rishi Raj  | Director | 25-Nov-2019 | Current |
| Kishansingh Ramsinghaney | Director | 17-Mar-1997 | Current |
| Anshul Gaurav | Director | 25-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Pharmax Corporation.
Pharmax Corporation Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 98.56% increase. The company also saw a substantial improvement in profitability, with a 442.31% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmax Corporation?
In 2023, Pharmax Corporation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Max Towers Private LimitedActive 8 years 1 monthKishansingh Ramsinghaney and Anshul Gaurav are mutual person
- Max Asset Services LimitedActive 8 years 3 months
Kishansingh Ramsinghaney and Rishi Raj are mutual person
- Max Estates 128 Private LimitedActive 18 years 4 months
Rishi Raj and Anshul Gaurav are mutual person
- Max Estates Gurgaon Two LimitedActive 11 months 17 days
Rishi Raj and Anshul Gaurav are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Feb 2024 | ₹50.00 Cr | Open |
Others Creation Date: 19 Oct 2022 | ₹68.00 Cr | Open |
Others Creation Date: 10 Nov 2021 | ₹65.00 Cr | Open |
How Many Employees Work at Pharmax Corporation?
Unlock and access historical data on people associated with Pharmax Corporation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmax Corporation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmax Corporation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
